应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CRBU Caribou Biosciences
休市中 05-02 16:00:00 EDT
0.8800
+0.0782
+9.75%
盘后
0.8799
-0.0001
-0.01%
19:48 EDT
最高
0.9124
最低
0.7932
成交量
102.35万
今开
0.8000
昨收
0.8018
日振幅
14.87%
总市值
8,184万
流通市值
7,387万
总股本
9,300万
成交额
88.06万
换手率
1.22%
流通股本
8,394万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Caribou Biosciences, Inc.盘中异动 临近午盘急速下跌5.15%报0.807美元
市场透视 · 05-01 15:46
Caribou Biosciences, Inc.盘中异动 临近午盘急速下跌5.15%报0.807美元
Caribou Biosciences, Inc.盘中异动 股价大跌5.35%报0.807美元
市场透视 · 04-30 14:04
Caribou Biosciences, Inc.盘中异动 股价大跌5.35%报0.807美元
Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.13%报0.734美元
市场透视 · 04-28
Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.13%报0.734美元
HC Wainwright & Co.:维持Caribou Biosciences(CRBU.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。
金融界 · 04-28
HC Wainwright & Co.:维持Caribou Biosciences(CRBU.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。
Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.81%
市场透视 · 04-25
Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.81%
Caribou Biosciences, Inc.盘中异动 股价大涨5.19%报0.837美元
市场透视 · 04-22
Caribou Biosciences, Inc.盘中异动 股价大涨5.19%报0.837美元
Caribou Biosciences, Inc.盘中异动 大幅下跌5.01%
市场透视 · 04-16
Caribou Biosciences, Inc.盘中异动 大幅下跌5.01%
Caribou Biosciences(CRBU.US):2024年Q4财报实现营收207.7万美元,前值为355.8万美元,预期值为184万美元;每股收益为-0.39美元,前值为-0.39美元,预期值为-0.42美元。
金融界 · 03-10
Caribou Biosciences(CRBU.US):2024年Q4财报实现营收207.7万美元,前值为355.8万美元,预期值为184万美元;每股收益为-0.39美元,前值为-0.39美元,预期值为-0.42美元。
Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39),超出预期$(0.42),销售额$2.08M,未达预期$2.11M
财报速递 · 03-10
Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39),超出预期$(0.42),销售额$2.08M,未达预期$2.11M
Caribou Biosciences, Inc.盘中异动 股价大跌5.08%
市场透视 · 03-10
Caribou Biosciences, Inc.盘中异动 股价大跌5.08%
Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元
市场透视 · 03-04
Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元
Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元
市场透视 · 03-03
Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元
Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元
市场透视 · 02-26
Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元
Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%
市场透视 · 02-25
Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%
Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元
市场透视 · 02-21
Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元
Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元
市场透视 · 02-18
Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元
Caribou Biosciences, Inc.盘中异动 急速拉升5.34%
市场透视 · 02-14
Caribou Biosciences, Inc.盘中异动 急速拉升5.34%
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.30%
市场透视 · 02-11
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.30%
Caribou Biosciences, Inc.盘中异动 早盘大幅跳水5.24%报1.36美元
市场透视 · 02-03
Caribou Biosciences, Inc.盘中异动 早盘大幅跳水5.24%报1.36美元
加载更多
公司概况
公司名称:
Caribou Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法,从而改变患有毁灭性疾病的患者的生活。
发行价格:
--
{"stockData":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":0.88,"timestamp":1746216000000,"preClose":0.8018,"halted":0,"volume":1023520,"hourTrading":{"tag":"盘后","latestPrice":0.8799,"preClose":0.88,"latestTime":"19:48 EDT","volume":8810,"amount":7719.557,"timestamp":1746229682126},"delay":0,"floatShares":83938299,"shares":93004602,"eps":-1.65089,"marketStatus":"休市中","change":0.0782,"latestTime":"05-02 16:00:00 EDT","open":0.8,"high":0.9124,"low":0.7932,"amount":880571.000368,"amplitude":0.148666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.65089,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":0.8018,"preHourTrading":{"tag":"盘前","latestPrice":0.84,"preClose":0.8018,"latestTime":"09:15 EDT","volume":39,"amount":32.171802,"timestamp":1746191701889},"postHourTrading":{"tag":"盘后","latestPrice":0.8799,"preClose":0.88,"latestTime":"19:48 EDT","volume":8810,"amount":7719.557,"timestamp":1746229682126},"volumeRatio":0.6365121392052491,"impliedVol":0.6187,"impliedVolPercentile":0.232},"requestUrl":"/m/hq/s/CRBU","defaultTab":"news","newsList":[{"id":"2532971007","title":"Caribou Biosciences, Inc.盘中异动 临近午盘急速下跌5.15%报0.807美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532971007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532971007?lang=zh_cn&edition=full","pubTime":"2025-05-01 23:46","pubTimestamp":1746114391,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日23时46分,Caribou Biosciences, Inc.股票出现波动,股价快速下挫5.15%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。该信息摘要如下:HC Wainwright & Co.:维持Caribou Biosciences评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050123463194ea07a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050123463194ea07a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2531055418","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.35%报0.807美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531055418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531055418?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:04","pubTimestamp":1746021883,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时04分,Caribou Biosciences, Inc.股票出现异动,股价急速跳水5.35%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。该信息摘要如下:HC Wainwright & Co.:维持Caribou Biosciences评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430220443a46dce64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430220443a46dce64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2531257574","title":"Caribou Biosciences, Inc.盘中异动 临近收盘股价大跌5.13%报0.734美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531257574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531257574?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:31","pubTimestamp":1745868681,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日03时31分,Caribou Biosciences, Inc.股票出现波动,股价大幅下跌5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.87%。其相关个股中,Portage Biotech Inc.、Cg Oncology, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Onconetix, Inc.较为活跃,换手率分别为2608.03%、519.47%、129.69%,振幅较大的相关个股有Relmada Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Cyclacel Pharmaceuticals, Inc.,振幅分别为68.35%、61.15%、60.43%。该信息摘要如下:HC Wainwright & Co.:维持Caribou Biosciences评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429033121a6cc15b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429033121a6cc15b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2531256232","title":"HC Wainwright & Co.:维持Caribou Biosciences(CRBU.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531256232","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531256232?lang=zh_cn&edition=full","pubTime":"2025-04-29 02:02","pubTimestamp":1745863372,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Caribou Biosciences(CRBU.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至3.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/29020249976215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRBU"],"gpt_icon":0},{"id":"2530134923","title":"Caribou Biosciences, Inc.盘中异动 早盘快速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530134923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530134923?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:48","pubTimestamp":1745588912,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时48分,Caribou Biosciences, Inc.股票出现波动,股价快速跳水5.81%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.00%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214832a6c82080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214832a6c82080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2529812275","title":"Caribou Biosciences, Inc.盘中异动 股价大涨5.19%报0.837美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529812275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529812275?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:47","pubTimestamp":1745329672,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时47分,Caribou Biosciences, Inc.股票出现异动,股价快速上涨5.19%。截至发稿,该股报0.837美元/股,成交量5.6383万股,换手率0.06%,振幅4.40%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.30%。其相关个股中,Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.、阿诺医药涨幅较大,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为177.00%、95.49%、56.90%,振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Ibio, Inc.,振幅分别为30.03%、23.53%、23.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222147529740bde1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504222147529740bde1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2528277224","title":"Caribou Biosciences, Inc.盘中异动 大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528277224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528277224?lang=zh_cn&edition=full","pubTime":"2025-04-17 00:16","pubTimestamp":1744820172,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日00时16分,Caribou Biosciences, Inc.股票出现异动,股价急速下跌5.01%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.18%。其相关个股中,Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Briacell Therapeutics Corp.、Transcode Therapeutics, Inc.、Pmgc Holdings Inc.较为活跃,换手率分别为499.05%、242.76%、178.62%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Dermata Therapeutics Inc C/Wts ,振幅分别为89.52%、49.00%、36.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417001612a45b528b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417001612a45b528b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2518778948","title":"Caribou Biosciences(CRBU.US):2024年Q4财报实现营收207.7万美元,前值为355.8万美元,预期值为184万美元;每股收益为-0.39美元,前值为-0.39美元,预期值为-0.42美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778948","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518778948?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"Caribou Biosciences(CRBU.US):2024年Q4财报实现营收207.7万美元,前值为355.8万美元,预期值为184万美元;每股收益为-0.39美元,前值为-0.39美元,预期值为-0.42美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRBU"],"gpt_icon":0},{"id":"1196872356","title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39),超出预期$(0.42),销售额$2.08M,未达预期$2.11M","url":"https://stock-news.laohu8.com/highlight/detail?id=1196872356","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196872356?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637684,"startTime":"0","endTime":"0","summary":"Caribou生物科学公司报告季度每股亏损$,比分析师普遍预期的$高7.14%。该公司报告季度销售额为$208万美元,未达分析师普遍预期的$211万美元,差距为1.39%。这比去年同期的$356万美元下降了41.62%。以上内容来自Benzinga Earnings专栏,原文如下:$Caribou Biosciences$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.08 million which missed the analyst consensus estimate of $2.11 million by 1.39 percent. This is a 41.62 percent decrease over sales of ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39),超出预期$(0.42),销售额$2.08M,未达预期$2.11M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU"],"gpt_icon":0},{"id":"2518820578","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518820578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518820578?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:58","pubTimestamp":1741625882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时58分,Caribou Biosciences, Inc.股票出现波动,股价急速跳水5.08%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.86%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2517398387","title":"Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517398387?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116374,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时26分,Caribou Biosciences, Inc.股票出现异动,股价大幅上涨5.14%。截至发稿,该股报1.13美元/股,成交量99.5745万股,换手率1.10%,振幅10.09%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"2516654565","title":"Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654565?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:18","pubTimestamp":1741025929,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时18分,Caribou Biosciences, Inc.股票出现异动,股价快速跳水5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大,Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为4364.36%、190.31%、179.16%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2514361862","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514361862?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:11","pubTimestamp":1740600700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时11分,Caribou Biosciences, Inc.股票出现异动,股价急速跳水5.24%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.78%。其相关个股中,Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃,换手率分别为6793.62%、321.58%、263.67%,振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为194.07%、81.11%、70.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2514781019","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514781019?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:13","pubTimestamp":1740500039,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时13分,Caribou Biosciences, Inc.股票出现波动,股价急速下挫6.25%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.53%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2513133372","title":"Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513133372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513133372?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:35","pubTimestamp":1740159331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时35分,Caribou Biosciences, Inc.股票出现波动,股价大幅下挫5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"2512166417","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166417?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890216,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分,Caribou Biosciences, Inc.股票出现异动,股价快速上涨5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.96%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2511692936","title":"Caribou Biosciences, Inc.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692936?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:46","pubTimestamp":1739547988,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时46分,Caribou Biosciences, Inc.股票出现波动,股价急速上涨5.34%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.58%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214234629abcf17ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214234629abcf17ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2510007336","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510007336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510007336?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:55","pubTimestamp":1739289358,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时55分,Caribou Biosciences, Inc.股票出现异动,股价急速下挫5.30%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.80%。其相关个股中,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2750.67%、1186.20%、389.74%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为58.60%、57.43%、40.87%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235558abcb18c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235558abcb18c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2508141795","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅跳水5.24%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141795?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:49","pubTimestamp":1738594163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时49分,Caribou Biosciences, Inc.股票出现异动,股价快速跳水5.24%。截至发稿,该股报1.36美元/股,成交量23.6856万股,换手率0.26%,振幅3.85%。Caribou Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Caribou Biosciences, Inc.公司简介:Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司,致力于通过应用其新型 CRISPR 平台, CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活,以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224923a2380dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224923a2380dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cariboubio.com","stockEarnings":[{"period":"1week","weight":0.137},{"period":"1month","weight":0.0221},{"period":"3month","weight":-0.3846},{"period":"6month","weight":-0.6018},{"period":"1year","weight":-0.7582},{"period":"ytd","weight":-0.4465}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法,从而改变患有毁灭性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.042916},{"month":2,"riseRate":0.25,"avgChangeRate":-0.02917},{"month":3,"riseRate":0,"avgChangeRate":-0.194501},{"month":4,"riseRate":0,"avgChangeRate":-0.1865},{"month":5,"riseRate":0.75,"avgChangeRate":-0.005289},{"month":6,"riseRate":0,"avgChangeRate":-0.271659},{"month":7,"riseRate":1,"avgChangeRate":0.533932},{"month":8,"riseRate":0.5,"avgChangeRate":0.161189},{"month":9,"riseRate":0.25,"avgChangeRate":-0.083644},{"month":10,"riseRate":0,"avgChangeRate":-0.097774},{"month":11,"riseRate":0.5,"avgChangeRate":0.132769},{"month":12,"riseRate":0,"avgChangeRate":-0.202888}],"exchange":"NASDAQ","name":"Caribou Biosciences","nameEN":"Caribou Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caribou Biosciences,CRBU,Caribou Biosciences股票,Caribou Biosciences股票老虎,Caribou Biosciences股票老虎国际,Caribou Biosciences行情,Caribou Biosciences股票行情,Caribou Biosciences股价,Caribou Biosciences股市,Caribou Biosciences股票价格,Caribou Biosciences股票交易,Caribou Biosciences股票购买,Caribou Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}